omniture
TERUMO CORPORATION

Latest News

Terumo Blood and Cell Technologies' Reveos® Automated Whole Blood Processing System Cleared by FDA for U.S. Commercial Use

Reveos is positioned to help U.S. blood centers supplement the platelet supply, reduce labor and co...

2023-08-01 20:30 1187

Terumo Blood and Cell Technologies' IMUGARD Platelet Pooling Set Cleared by FDA

IMUGARD to Help Strained U.S. Platelet Supply Meet Growing Need LAKEWOOD, Colo., Feb. 16, 2023 /PRN...

2023-02-17 03:48 1714

New Randomized Controlled Study Published in JAMA Demonstrates the Value of Clinical Decision Support Tools in Preventing Acute Kidney Injury in Patients Undergoing Coronary Angiography

–  Researchers used Terumo Health Outcomes' ePRISM® software to calculate safe contrast volume targ...

2022-11-01 20:00 1187

Terumo Announces Change in Indication for Dexcom G6 CGM System in Japan

Adjunctive use of Blood Glucose Meter Principally Not Required TOKYO, May 16, 2022 /PRNewswire/ -- ...

2022-05-16 15:19 3075

Terumo and Glooko Announce Collaboration on New Solution for Diabetes Data Sharing

A Technology Integration for MEDISAFE WITHTM Insulin Patch Pump Patients to Upload Data Anytime Any...

2022-03-30 15:00 3353

Terumo Establishes Group-wide 'DE&I Philosophy' to Further Cultivate a Diverse, Equitable and Inclusive Culture

TOKYO, Mar. 1, 2022 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced that it has esta...

2022-03-01 09:00 1824

Terumo and Corazon Sign Collaboration and Co-Marketing Agreement

SOMERSET, N.J., Feb. 25, 2022 /PRNewswire/ -- Terumo Health Outcomes, a division of Terumo Medical ...

2022-02-25 22:00 3249

Terumo Medical Corporation Applauds ACC/AHA/SCAI Decision to Designate Radial Access Class 1, Level of Evidence A

SOMERSET, N.J., Jan. 11, 2022 /PRNewswire/ -- Terumo Medical Corporation (TMC) applauds the publica...

2022-01-12 03:40 1866

Terumo Corporation and Diabeloop SA. Enter into Comprehensive Strategic Partnership Agreement to Expand Their Diabetes Care Offerings

TOKYO and PARIS, Nov. 17, 2021 /PRNewswire/ -- Terumo Corporation, a global leader in medical techn...

2021-11-17 16:00 1610

Terumo Blood and Cell Technologies and Immunicom Establish Agreement to Launch Breakthrough Cancer Immunotherapy Treatment in Europe

* The therapy aims to re-energize a patient's immune system to fight cancer tumors * Initial co...

2021-11-17 00:00 1448

Terumo Celebrates 100th Anniversary of Contributing to Society Through Healthcare

TOKYO, Sept. 17, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543), a global leader in medical ...

2021-09-17 15:30 2968

Terumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy

1 in 3 people will be diagnosed with cancer in their lifetime1 LAKEWOOD, Colo. and FORT COLLINS, Co...

2021-08-11 23:00 21539

Terumo and UMCU strengthen their partnership to develop solutions in Interventional Oncology

LEUVEN, Belgium, July 20, 2021 /PRNewswire/ -- Terumo Europe and University Medical Center Utrecht ...

2021-07-20 22:54 12421

Terumo Introduces New AZUR™ Vascular Plug and PG Pro™ Peripheral Microcatheter Embolization System

SOMERSET, N.J., July 14, 2021 /PRNewswire/ -- Terumo Medical Corporation (TMC) has announced today ...

2021-07-14 20:00 30387

Terumo Donates Additional USD 1 Million to Support the COVID-19 Solidarity Response Fund for WHO

TOKYO, May 14, 2021 /PRNewswire/ -- As the world joins together to fight the ongoing battle against...

2021-05-14 09:05 5765

Terumo Blood and Cell Technologies and CSL Plasma Announce Collaboration to Deliver New Plasma Collection Platform

LAKEWOOD, Colo. and BOCA RATON, Fla., April 19, 2021 /PRNewswire/ -- Terumo Blood and Cell Techno...

2021-04-20 05:00 2077

Terumo is building a Global Therapeutic Interventional Oncology team to offer more therapeutic solution to cancer patients

LEUVEN, Belgium, April 12, 2021 /PRNewswire/ -- Terumo is proud to announce the launch of its Globa...

2021-04-12 22:25 3008

Terumo Signs a Definitive Agreement to Acquire All Assets of Health Outcomes Sciences, Inc.

TOKYO, Feb. 23, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543), a global leader in medical tec...

2021-02-24 07:00 8226

A Novel Drug-Device Combination Product Using Terumo's Automated Injection Device Completes Clinical Study in Japan

TOKYO, Feb. 8, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced the completion o...

2021-02-08 09:00 3047

Terumo Enters 100th Anniversary Year

TOKYO, Jan. 5, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543) is celebrating its 100th anniver...

2021-01-05 15:00 10801